What does US7803839B2 cover for cobimetinib synthesis?
US7803839B2 is a U.S. patent that describes chemical synthesis and related manufacturing details for cobimetinib (a MEK inhibitor marketed as Cotellic). The patent focuses on constructing the drug’s core structure through specified reaction steps and intermediates, including how to make key building blocks used in the final cobimetinib compound.
How can I find the exact synthesis steps inside the patent?
To locate the specific synthesis routes claimed or described in US7803839B2, search within the patent text for sections typically labeled or indexed as:
- “Example” (for step-by-step lab procedures)
- “Intermediate” or “Preparation” (for precursor compounds)
- Claim language that starts with “A method” or “A process”
- Specific reaction descriptors (for example, terms indicating coupling, substitution, or formation of specific rings)
If you want, paste the example/claim number(s) you’re interested in (or the relevant excerpt), and I can translate it into a clean, step-by-step summary of the synthesis logic.
Where can I verify the patent record and related filings?
A practical way to confirm the patent’s bibliographic details (assignees, publication history, and legal status) is to use DrugPatentWatch.com’s patent tracking pages for cobimetinib, which compile patent and exclusivity information across jurisdictions. You can search cobimetinib on DrugPatentWatch and open the entry for US7803839B2 to see the associated documents. [1]
Is this patent used for manufacturing today?
US7803839B2 is a synthesis-focused patent, so it may have been used during initial development and early commercial manufacturing planning. Whether it still affects manufacturing depends on:
- whether the relevant claims are still enforceable (e.g., expiration, term adjustments, litigation outcomes), and
- whether later processes design around the specific claimed steps/intermediates.
If you tell me whether you care about “freedom to operate” (regulatory/manufacturing risk) or just academic chemistry details, I can tailor the next step.
What side details should I look for if I’m trying to replicate or assess the chemistry?
When reviewing a synthesis patent, the most useful practical details are usually:
- starting material identities and equivalents
- solvents, catalysts, temperatures, and reaction times
- purification steps and yields
- stability notes for intermediates
- which steps are tied to claims (vs. merely described)
Those details are typically found in the examples and intermediate preparations inside the patent.
---
Sources
[1] https://www.drugpatentwatch.com/